Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are both used to diagnose diabetes, but these measurements can identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening, had elevated FPG, HbA1c or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardized proportion of diabetes that was previously undiagnosed and detected in survey screening ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the age-standardized proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c was more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global shortfall in diabetes diagnosis and surveillance

Robust estimation of bacterial cell count from optical density

Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

Background Underweight and obesity are associated with adverse health outcomes throughout the life course. We estimated the individual and combined prevalence of underweight or thinness and obesity, and their changes, from 1990 to 2022 for adults and school-aged children and adolescents in 200 countries and territories. Methods We used data from 3663 population-based studies with 222 million participants that measured height and weight in representative samples of the general population. We used a Bayesian hierarchical model to estimate trends in the prevalence of different BMI categories, separately for adults (age ≥20 years) and school-aged children and adolescents (age 5–19 years), from 1990 to 2022 for 200 countries and territories. For adults, we report the individual and combined prevalence of underweight (BMI <18·5 kg/m2) and obesity (BMI ≥30 kg/m2). For schoolaged children and adolescents, we report thinness (BMI <2 SD below the median of the WHO growth reference) and obesity (BMI >2 SD above the median). Findings From 1990 to 2022, the combined prevalence of underweight and obesity in adults decreased in 11 countries (6%) for women and 17 (9%) for men with a posterior probability of at least 0·80 that the observed changes were true decreases. The combined prevalence increased in 162 countries (81%) for women and 140 countries (70%) for men with a posterior probability of at least 0·80. In 2022, the combined prevalence of underweight and obesity was highest in island nations in the Caribbean and Polynesia and Micronesia, and countries in the Middle East and north Africa. Obesity prevalence was higher than underweight with posterior probability of at least 0·80 in 177 countries (89%) for women and 145 (73%) for men in 2022, whereas the converse was true in 16 countries (8%) for women, and 39 (20%) for men. From 1990 to 2022, the combined prevalence of thinness and obesity decreased among girls in five countries (3%) and among boys in 15 countries (8%) with a posterior probability of at least 0·80, and increased among girls in 140 countries (70%) and boys in 137 countries (69%) with a posterior probability of at least 0·80. The countries with highest combined prevalence of thinness and obesity in school-aged children and adolescents in 2022 were in Polynesia and Micronesia and the Caribbean for both sexes, and Chile and Qatar for boys. Combined prevalence was also high in some countries in south Asia, such as India and Pakistan, where thinness remained prevalent despite having declined. In 2022, obesity in school-aged children and adolescents was more prevalent than thinness with a posterior probability of at least 0·80 among girls in 133 countries (67%) and boys in 125 countries (63%), whereas the converse was true in 35 countries (18%) and 42 countries (21%), respectively. In almost all countries for both adults and school-aged children and adolescents, the increases in double burden were driven by increases in obesity, and decreases in double burden by declining underweight or thinness. Interpretation The combined burden of underweight and obesity has increased in most countries, driven by an increase in obesity, while underweight and thinness remain prevalent in south Asia and parts of Africa. A healthy nutrition transition that enhances access to nutritious foods is needed to address the remaining burden of underweight while curbing and reversing the increase in obesit

Global variations in diabetes mellitus based on fasting glucose and haemogloblin A1c

Fasting plasma glucose (FPG) and haemoglobin A1c (HbA1c) are both used to diagnose diabetes, but may identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening had elevated FPG, HbA1c, or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardised proportion of diabetes that was previously undiagnosed, and detected in survey screening, ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the agestandardised proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global gap in diabetes diagnosis and surveillance.peer-reviewe

Synthesis of Scutellarein Derivatives with a Long Aliphatic Chain and Their Biological Evaluation against Human Cancer Cells

Scutellarin is the major active flavonoid extracted from the traditional Chinese herbal medicine Erigeron breviscapus (Vant.) Hand-Mazz., which is widely used in China. Recently, accumulating evidence has highlighted the potential role of scutellarin and its main metabolite scutellarein in the treatment of cancer. To explore novel anticancer agents with high efficiency, a series of new scutellarein derivatives with a long aliphatic chain were synthesized, and the antiproliferative activities against Jurkat, HCT-116 and MDA-MB-231 cancer cell lines were assessed. Among them, compound 6a exhibited the strongest antiproliferative effects on Jurkat (IC50 = 1.80 μM), HCT-116 (IC50 = 11.50 μM) and MDA-MB-231 (IC50 = 53.91 μM). In particular, 6a even showed stronger antiproliferative effects than the positive control NaAsO2 on Jurkat and HCT-116 cell lines. The results showed that a proper long aliphatic chain enhanced the antiproliferative activity of scutellarein

SiO₂ Modification of Silicon Carbide Membrane via an Interfacial In Situ Sol–Gel Process for Improved Filtration Performance

Silicon carbide (SiC) membrane has emerged as a promising class of inorganic ceramic membranes with many advantageous attributes and has been used for a variety of industrial microfiltration (MF) processes. The state-of-the-art industrial manufacturing of SiC membranes based on the particle sintering method can only achieve an average pore size that ranges from 40 nm to a few micrometers, which is still unsatisfactory for ultrafiltration (UF) applications. Thus, the pore size control of SiC membranes remains a focus of continuing study. Herein, we provide an in situ sol–gel modification strategy to tailor the pore size of SiC membranes by a superficial deposition of SiO2 onto the membrane surface and membrane pore channels. Our in situ sol–gel modification method is simple and effective. Furthermore, the physical characteristics and the filtration performance of the membrane can easily be controlled by the in situ reaction time. With an optimal in situ reaction time of 30 min, the average pore size of the membrane can be reduced from macropores (400 nm) to mesopores (below 20 nm), and the retention ability for 20 nm fluorescent PS microspheres can be improved from 5% to 93%; the resultant SiC/SiO2 composite membranes are imparted with water permeance of 77 L·m−2·h−1·bar−1, improved anti-protein-fouling properties, excellent performance, and anti-acid stabilities. Therefore, modified SiC/SiO2 membranes based on the in situ sol–gel process have great potential as UF membranes for a variety of industrial processes

Porous Materials from Thermally Activated Kaolinite: Preparation, Characterization and Application

In the present study, porous alumina/silica materials were prepared by selective leaching of silicon/aluminum constituents from thermal-activated kaolinite in inorganic acid or alkali liquor. The correlations between the characteristics of the prepared porous materials and the dissolution properties of activated kaolinite were also investigated. The results show that the specific surface area (SSA) of porous alumina/silica increases with silica/alumina dissolution, but without marked change of the BJH pore size. Furthermore, change in pore volume is more dependent on activation temperature. The porous alumina and silica obtained from alkali leaching of kaolinite activated at 1150 °C for 15 min and acid leaching of kaolinite activated at 850 °C for 15 min are mesoporous, with SSAs, BJH pore sizes and pore volumes of 55.8 m2/g and 280.3 m2/g, 6.06 nm and 3.06 nm, 0.1455 mL/g and 0.1945 mL/g, respectively. According to the adsorption tests, porous alumina has superior adsorption capacities for Cu2+, Pb2+ and Cd2+ compared with porous silica and activated carbon. The maximum capacities of porous alumina for Cu2+, Pb2+ and Cd2+ are 134 mg/g, 183 mg/g and 195 mg/g, respectively, at 30 °C

Spatiotemporal analysis of the future carbon footprint of solar electricity in the United States by a dynamic life cycle assessment

Summary: Solar photovoltaics (PVs) installation would increase 20-fold by 2050; however, considerable greenhouse gas (GHG) emissions are generated during the cradle-to-gate production, with spatiotemporal variances depending on the grid emission. Thus, a dynamic life cycle assessment (LCA) model was developed to assess the accumulated PV panels with a heterogeneous carbon footprint if manufactured and installed in the United States. The state-level carbon footprint of solar electricity (CFEPV-avg) from 2022 to 2050 was estimated using several cradle-to-gate production scenarios to account for emissions stemming from electricity generated from solar PVs. The CFEPV-avg (min 0.032, max 0.051, weighted avg. 0.040 kg CO2-eq/kWh) in 2050 will be significantly lower than that of the comparison benchmark (min 0.047, max 0.068, weighted avg. 0.056 kg CO2-eq/kWh). The proposed dynamic LCA framework is promising for planning solar PV supply chains and, ultimately, the supply chain of an entire carbon-neutral energy system to maximize the environmental benefits